Selecta Biosciences

Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company that is focused on unlocking the full potential of biologic therapies by mitigating unwanted immune responses.

Industries

Biotechnology

Headquarters

Watertown, United States

Stage

Post IPO Equity

Employees

51-200

Links

Org chart

Carsten Brunn

President and CEO

Collapse

Blaine Davis

CFO

Lloyd Johnston

COO

Takashi Kei Kishimoto

Chief Scientific Officer

Peter G. Traber

Chief Medical Officer

Kristen Baldwin

Chief People Officer

Elona Kogan

General Counsel and Corporate

Jean-Paul Rodrique

Vice President, Quality

Marina Orlova

Chief Strategy Officer

Matthew Bartholomae

General Counsel, Secretary

Omid Farokhzad

Director, Chairman (2008 - 2019) and Founder

Petr Ilyinskii

Vice President

Rehan Azeem, MD, MPH

Vice President, Clinical Development

Robyn Willis

Vice President, Regulatory Affairs

Wes DeHaan

Vice President Program Management

Teams

View all

Board of Directors

8 members

Leadership Team

6 members

CEO and Executive Team

5 members

Discover similar companies

Voyager Therapeutics

Cambridge, United States · Post IPO Equity

Exicure

Skokie, United States · Post IPO Equity

AllStripes

San Francisco, United States · Series B

Mission Bio

San Francisco, United States · Series C

Korro Bio

Cambridge, United States · Series B

Sutro Biopharma

South San Francisco, United States · Post IPO Equity

Illumina

San Diego, United States

MassBio

Cambridge, United States

CytomX

South San Francisco, United States

Axsome Therapeutics

New York, United States · Post IPO Equity

Cerus

Concord, United States · Post IPO Equity

Verge Genomics

South San Francisco, United States · Series B

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.